Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Waters

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
AIDS Research and Human Retroviruses|September 12, 2019
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 InfectionMarta Boffito, Laura Waters, Pedro Cahn, et al.
Advances in Radiation Oncology|July 6, 2023
Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle InvolvementScarlett Acklin-Wehnert, David Carpenter, Divya Natesan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) EraGiovanni Guaraldi, Jovana Milic, Esteban Martinez, et al.
BMC Infectious Diseases|July 22, 2020
A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trialCollins C Iwuji, Duncan Churchill, Stephen Bremner, et al.
International Journal of STD & AIDS|April 21, 2016
UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015Fiona Cresswell, Laura Waters, Eleanor Briggs, et al.
HIV Medicine|July 17, 2025
CROI 2025 BHIVA working group summaryCaroline A Sabin, Tristan J Barber, Laura Waters, et al.
Genomics|April 1, 2010
Investigation of low-dose ritonavir on human peripheral blood mononuclear cells using gene expression whole genome microarraysSaliha Yilmaz, Marta Boffito, Sophie Collot-Teixeira, et al.
Advances in Radiation Oncology|April 7, 2022
Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate CancerDivya Natesan, David J Carpenter, Warren Floyd, et al.
Annals of Internal Medicine|February 28, 2022
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug InteractionsCatia Marzolini, Daniel R Kuritzkes, Fiona Marra, et al.
AIDS (London, England)|April 1, 2026
Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIVJames Mason, Manik Kohli, Ebun Taiwo, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
AIDS Research and Human Retroviruses|September 12, 2019
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 InfectionMarta Boffito, Laura Waters, Pedro Cahn, et al.
Advances in Radiation Oncology|July 6, 2023
Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle InvolvementScarlett Acklin-Wehnert, David Carpenter, Divya Natesan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) EraGiovanni Guaraldi, Jovana Milic, Esteban Martinez, et al.
BMC Infectious Diseases|July 22, 2020
A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trialCollins C Iwuji, Duncan Churchill, Stephen Bremner, et al.
International Journal of STD & AIDS|April 21, 2016
UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015Fiona Cresswell, Laura Waters, Eleanor Briggs, et al.
HIV Medicine|July 17, 2025
CROI 2025 BHIVA working group summaryCaroline A Sabin, Tristan J Barber, Laura Waters, et al.
Genomics|April 1, 2010
Investigation of low-dose ritonavir on human peripheral blood mononuclear cells using gene expression whole genome microarraysSaliha Yilmaz, Marta Boffito, Sophie Collot-Teixeira, et al.
Advances in Radiation Oncology|April 7, 2022
Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate CancerDivya Natesan, David J Carpenter, Warren Floyd, et al.
Annals of Internal Medicine|February 28, 2022
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug InteractionsCatia Marzolini, Daniel R Kuritzkes, Fiona Marra, et al.
AIDS (London, England)|April 1, 2026
Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIVJames Mason, Manik Kohli, Ebun Taiwo, et al.
Pageof 14